Related Experiment Video
Updated: Jan 16, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
CAPTURE and PUMA as Case-Finding Tools in Patients at Risk of COPD-A Multicenter Mexican Experience
Arturo Cortes-Telles1, Ismael Juarez-de-Dios2, Esperanza Figueroa-Hurtado1
1Clinica de Enfermedades Respiratorias, Hospital Regional de Alta Especialidad de la Peninsula de Yucatan IMSS-Bienestar, Merida 97130, Mexico.
This study evaluated PUMA and CAPTURE questionnaires for screening chronic obstructive pulmonary disease (COPD) in Mexico. Both tools showed moderate accuracy in identifying patients with spirometric evidence of COPD.
Area of Science:
- Pulmonology
- Epidemiology
- Public Health
Background:
- Chronic obstructive pulmonary disease (COPD) poses a significant global health burden.
- Underdiagnosis is prevalent in low- and middle-income countries due to limited spirometry access.
- Effective case-finding strategies are needed for routine clinical practice.
Purpose of the Study:
- To compare the effectiveness of PUMA and CAPTURE questionnaires for COPD screening in Mexican adults.
- To evaluate the sensitivity and specificity of these questionnaires in identifying spirometric obstructive patterns.
- To assess the correlation of questionnaire scores with FEV1/FVC ratios.
Main Methods:
- A multicenter, cross-sectional study involving COPD screening campaigns.
- Adults over 40 with risk factors (smoking, biomass exposure) were enrolled.
- COPD diagnosis confirmed by post-bronchodilator FEV1/FVC < 0.70; sensitivity, specificity, and ROC curves analyzed.
Main Results:
- COPD was diagnosed in 37.1% of 197 participants.
- PUMA questionnaire achieved 74.0% sensitivity and 51.6% specificity (cut-off ≥6).
- CAPTURE questionnaire showed varying results: ≥3 (76.9% sensitivity, 40.9% specificity) or ≥4 (61.5% sensitivity, 72.7% specificity).
- Both questionnaires demonstrated moderate accuracy (ROC 0.693 for PUMA, 0.714 for CAPTURE) and significant negative correlations with FEV1/FVC.
Conclusions:
- PUMA and CAPTURE questionnaires offer moderate certainty for diagnosing patients at risk of COPD with spirometric obstruction in Mexican populations.
- These tools can aid in identifying at-risk individuals in primary care settings.
- Further validation in diverse populations is warranted.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

